Invention Grant
- Patent Title: Methods of decreasing glycosylated hemoglobin in patients with dyslipidemia
- Patent Title (中): 降低血脂异常患者糖化血红蛋白的方法
-
Application No.: US13553271Application Date: 2012-07-19
-
Publication No.: US08846758B2Publication Date: 2014-09-30
- Inventor: Mannching Sherry Ku , Chih-Kuang Chen , Wei-Shu Lu , Chih-Ming Chen , I-Yin Lin
- Applicant: Mannching Sherry Ku , Chih-Kuang Chen , Wei-Shu Lu , Chih-Ming Chen , I-Yin Lin
- Applicant Address: TW Taipei
- Assignee: TWi Biotechnology, Inc.
- Current Assignee: TWi Biotechnology, Inc.
- Current Assignee Address: TW Taipei
- Agency: Wood, Phillips, Katz, Clark & Mortimer
- Main IPC: A01N37/02
- IPC: A01N37/02 ; A01N37/10 ; A61K31/225 ; C07C50/18 ; A61K45/06 ; A61K38/17 ; A61K31/235
Abstract:
Methods for treating abnormal glycosylated hemoglobin (HbA1c) levels in a patient in need thereof, wherein the provided methods comprise administering to a patient in need a therapeutically effective amount of an Interleukin-1β modulator. Also, the invention provides compositions comprising at least one lipid modifying agent and an IL-1β modulator.
Public/Granted literature
- US20130022610A1 METHODS OF DECREASING GLYCOSYLATED HEMOGLOBIN IN PATIENTS WITH DYSLIPIDEMIA Public/Granted day:2013-01-24
Information query
